Renal dopaminergic system: Pathophysiological implications and clinical perspectives

doi:10.5527/wjn.v4.i2.196

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14913)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

748

WORD

353

HTML

11402

Figures (1-5)

358

Tables (1-2)

306

Sum=13167

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

747

Download

999

Sum=1746

May 6, 2015 (publication date) through Jan 3, 2025

Times Cited of This Article

Times Cited (54)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Nephrol. May 6, 2015; 4(2): 196-212
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.196

Full Size Figure Download Figure

Figure 5 Impaired interactions between ANP and renal dopamine in nephrotic syndrome. Full lines: Stimulation; stripped lines: Inhibition. PDE5: Phosphodiesterase type 5.

Citation: Choi MR, Kouyoumdzian NM, Rukavina Mikusic NL, Kravetz MC, Rosón MI, Rodríguez Fermepin M, Fernández BE. Renal dopaminergic system: Pathophysiological implications and clinical perspectives. World J Nephrol 2015; 4(2): 196-212
URL: https://www.wjgnet.com/2220-6124/full/v4/i2/196.htm
DOI: https://dx.doi.org/10.5527/wjn.v4.i2.196